28 related articles for article (PubMed ID: 1551544)
1. Ursodeoxycholic acid for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid in the treatment of liver diseases.
Saksena S; Tandon RK
Postgrad Med J; 1997 Feb; 73(856):75-80. PubMed ID: 9122101
[TBL] [Abstract][Full Text] [Related]
3. Oral bile acids in cystic fibrosis-associated liver disease.
Colombo C; Crosignani A; Apostolo MG; Marzano MT; Bettinardi N; Giunta A
J R Soc Med; 1994; 87 Suppl 21(Suppl 21):20-4. PubMed ID: 8201582
[No Abstract] [Full Text] [Related]
4. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
5. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
7. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
[TBL] [Abstract][Full Text] [Related]
8. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis.
Quarneti C; Muratori P; Lalanne C; Fabbri A; Menichella R; Granito A; Masi C; Lenzi M; Cassani F; Pappas G; Muratori L
Liver Int; 2015 Feb; 35(2):636-41. PubMed ID: 24698666
[TBL] [Abstract][Full Text] [Related]
9. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy.
Perdigoto R; Wiesner RH
Gastroenterology; 1992 Apr; 102(4 Pt 1):1389-91. PubMed ID: 1551544
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
Abbas G; Lindor KD
Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
[TBL] [Abstract][Full Text] [Related]
11. [Ursodeoxycholic acid therapy in biliary cirrhosis].
Herszényi L; Szalay L; Schaff Z; Gergely P; Fehér J
Orv Hetil; 1993 Sep; 134(38):2085-9. PubMed ID: 8414454
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
